$3.36
0.59% day before yesterday
Nasdaq, Jun 06, 10:00 pm CET
ISIN
US29273B1044
Symbol
NDRA
Sector
Industry

ENDRA Life Sciences Inc. Stock price

$3.36
-2.62 43.85% 1M
-1.93 36.48% 6M
-2.90 46.33% YTD
-198.42 98.33% 1Y
-32,196.64 99.99% 5Y
-136,496.64 100.00% 10Y
-136,496.64 100.00% 20Y
Nasdaq, Closing price Fri, Jun 06 2025
-0.02 0.59%
ISIN
US29273B1044
Symbol
NDRA
Sector
Industry

Key metrics

Market capitalization $2.48m
Enterprise Value $420.00k
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 1.08
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-9.51m
Free Cash Flow (TTM) Free Cash Flow $-6.56m
Cash position $2.06m
EPS (TTM) EPS $-17.52
Short interest 9.04%
Show more

Is ENDRA Life Sciences Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,823 stocks worldwide.

ENDRA Life Sciences Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast ENDRA Life Sciences Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast ENDRA Life Sciences Inc.:

Buy
100%

Financial data from ENDRA Life Sciences Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 6.82 6.82
19% 19%
-
- Research and Development Expense 2.68 2.68
42% 42%
-
-9.31 -9.31
9% 9%
-
- Depreciation and Amortization 0.19 0.19
27% 27%
-
EBIT (Operating Income) EBIT -9.51 -9.51
8% 8%
-
Net Profit -9.77 -9.77
1% 1%
-

In millions USD.

Don't miss a Thing! We will send you all news about ENDRA Life Sciences Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ENDRA Life Sciences Inc. Stock News

Neutral
Business Wire
24 days ago
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today provided a business update and reported financial results for the three months ended March 31, 2025. Business Update Incorporating Liver Diagnostics into the Management of Metabolic Disease ENDRA recently announced a strategic pivot to position the company...
Neutral
Business Wire
2 months ago
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today announced a new strategic direction to develop and deploy its TAEUS system as a biomarker solution for the early detection and management of metabolic diseases in patients being treated with glucagon-like peptide-1 (GLP-1) drugs and other metabolic dysfunc...
Neutral
Business Wire
2 months ago
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the fourth quarter and full-year ended December 31, 2024, and provided a business update. Business Update ENDRA made significant progress against many of the new initiatives discussed during the Company's August 22, 2024, con...

Company Profile

ENDRA Life Sciences, Inc. develops medical imaging technology. It operates Thermo-Acoustic Enhanced UltraSound platform to enable clinicians to visualize human tissue composition, function and temperature. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.

Head office United States
CEO Alexander Tokman
Employees 21
Founded 2007
Website www.endrainc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today